The requirement to obtain a license as a terminal distributor with an office-based opioid treatment classification takes effect on August 4, 2017.
While the deadline for licensure is not until August, the Board plans to open the licensing process well in advance to allow enough time for those impacted to obtain licensure. The opening of the licensing process is anticipated late April. Updates will be posted to the Board of Pharmacy’s website.
There is a $150 fee per year for the classification, along with an application. The application will be available as soon as the week of April 17. Because FQHCs aren’t physician owned they will also have to seek a waiver of that requirement from the board, but it will be explained on the application on how to do just that. It is recommended to submit as early as possible because it can take some time to approve due to background checks that are required.
Please review this FAQ document, compiled by the Ohio Pharmacy Board last month, which includes good information not limited to the following:
What if I already have a terminal distributor license?
You will need to apply for a license as a terminal distributor of dangerous drugs with an office-based opioid treatment classification. The office-based opioid treatment license will take the place of your existing terminal distributor license.
I work in a multi-physician practice where each physician provides office-based opioid treatment to fewer than 30 patients. Is my practice required to obtain licensure?
No. The law requires licensure for any location where a prescriber is treating more than thirty individuals for opioid dependence or addiction using a controlled substance.
Please contact Randy or Julie at OACHC with any questions.